Deal history
21 participations| Date | Company | Round | Raised | Post-money | Role |
|---|---|---|---|---|---|
| Sep 2026 | Crusoe | Series F | ▮ | ▮ | ▮ |
| Sep 2026 | Superluminal Medicines | Series B | ▮ | ▮ | ▮ |
| Sep 2026 | iPronics | Series B | ▮ | ▮ | ▮ |
+ 18 more deals · all 21, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | |||||
Investment activity
Nvidia joined 16 recorded rounds in the last two years (12 in the last 12 months), up from 5 in the two years before. By year: 12 in 2026, 3 in 2025 and 5 in 2024. Across all 21 recorded rounds, 11 were early-stage and 10 were later-stage. Nvidia is recorded as lead on 1 of them. 4 rounds landed in the last 90 days. Nvidia most often invests alongside Coatue Management (5 shared rounds), Fidelity (4 shared rounds) and General Catalyst (4 shared rounds). Most recently: Superluminal Medicines (Series B, Sep 2026) and Crusoe (Series F, Sep 2026).
Free account
See more of the book
- ·The top 10 names in the book — of 131 recorded positions
- ·The 10 latest deals — of 21 rounds
- ·Watchlist + alerts for Nvidia's activity